bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2018: N O S A J J M A M F J
2017: D N

 
  Other news for:
Neoplasms
Environment
 Resources from HONselect
Human Cancer Meds Might Help Save Tasmanian Devils

By Robert Preidt

TUESDAY, April 10, 2018 (HealthDay News) -- Drugs that fight cancer in people could help treat cancers that put Tasmanian devils at risk of extinction, researchers report.

They found that two transmissible cancers -- devil facial tumor 1 (DFT1) and devil facial tumor 2 (DFT2) -- are closely related and that molecules called receptor tyrosine kinases (RTKs) play an important role in both.

Some human cancer drugs target RTKs. In lab tests, these drugs also stopped growth of the two cancers that afflict Tasmanian devils. It may be possible to use them to treat the devil facial tumor cancers, according to researchers at the University of Cambridge in England.

"Altogether, our findings suggest that transmissible cancers may arise naturally in Tasmanian devils. We found no DNA-level evidence of these cancers being caused by external factors or infectious agents such as viruses," first author Maximilian Stammnitz said in a university news release. He is a doctoral student in the Transmissible Cancer Group.

DFT1 is known to spread by biting, and that's probably also true for DFT2, according to the researchers. Both cancers go undetected by the devil's immune system.

Tasmanian devils are the world's largest carnivorous marsupials, found wild only on the island of Tasmania, Australia. The DFT1 cancer was first noted in northeast Tasmania in 1996 and has since spread throughout the island, causing significant declines in devil numbers. DFT2 was discovered in 2014 and appears to be limited to a peninsula in Tasmania's southeast.

"The discovery of a second transmissible cancer in Tasmanian devils was a huge surprise," said research team leader Elizabeth Murchison. She is a group leader in the Department of Veterinary Medicine.

"Other than these two cancers, we know of only one other naturally occurring transmissible cancer in mammals -- the canine transmissible venereal tumor in dogs, which first emerged several thousand years ago," she explained.

Murchison said the story of Tasmanian devils being killed off by disease in recent years has been troubling.

"This study gives us optimism that anti-cancer drugs that are already in use in humans may offer a chance to assist with conservation efforts for this iconic animal," she said.

The study was published April 9 in the journal Cancer Cell.

More information

The Tasmania Parks and Wildlife Service has more on the Tasmanian devil.

SOURCE: University of Cambridge, news release, April 9, 2018

Copyright © 2018 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=732720

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Neoplasms
Specialty Chemicals and Products
Research Personnel
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact